Longridge Advisors helps private equity firms and corporate acquirers make better investment decisions. We provide rigorous, independent commercial due diligence and market strategy work — with the depth of a specialist and the judgment of experienced investors.
Longridge Advisors is a boutique advisory firm specialising in commercial due diligence and market strategy for investors and corporates across Europe and beyond.
We exist because we believe the best diligence work comes from senior people who stay close to the detail — not from large teams where your project gets delegated three levels down. Every engagement at Longridge is led by a principal with direct transaction experience and deep sector knowledge.
Our clients are private equity funds, family offices, and corporate development teams who value candour over polish. We tell you what we actually think — about the market, the thesis, the management team, and the risks that matter.
We are based in Europe and work globally, with particular depth in the DACH region, the UK, and the Nordics. Our backgrounds span strategy consulting, investment banking, and operating roles in the industries we advise on.
Independent, fact-based assessment of a target's commercial position, market dynamics, and growth prospects. We focus on what will matter to you as an owner — not on producing a 200-page document that gathers dust.
Deep market intelligence for investment screening, portfolio strategy, and sector mapping — when you need to understand a market before a specific deal is on the table.
Post-acquisition commercial strategy work for portfolio companies. We help you turn diligence findings into an actionable growth plan in the first 100 days and beyond.
Vendor-side commercial analysis that helps you present the equity story with rigour and credibility — giving buyers confidence and maximising competitive tension.
We start with your investment thesis and the key uncertainties. No boilerplate scope — every workstream is designed around the specific questions you need answered.
Primary research with customers, competitors, and industry experts. Proprietary data analysis. We triangulate relentlessly — we don't just report what management told us.
We pressure-test the thesis from every angle. If the plan says 8% growth, we build the case for why it could be 4% — or 12%. You get the full picture, not a confirmation exercise.
A clear, concise deliverable built for decision-makers. Key findings, risks, opportunities, and a view on value creation — typically within 3–5 weeks.
Why seemingly consolidated markets still offer compelling buy-and-build opportunities for patient capital.
A framework for assessing revenue concentration risk that goes beyond the headline numbers.
Why the calibration services market ticks every box for PE investors seeking resilient, recurring-revenue platforms.
We work with a select number of clients at any given time, which means every engagement gets our full attention. If you'd like to explore working together, reach out — we typically respond within 24 hours.